title: Rosuvastatin: winner in the statin wars, patients' health notwithstanding.
authors: Sidney
authors: S
authors: Wolfe
mesh_terms: D000329:Advertising; D017277:Drug Approval; D005464:Fluorobenzenes / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000139:chemically induced; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use*; D012206:Rhabdomyolysis / Q000139:chemically induced; D018570:Risk Assessment; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium